🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial is studying the side effects and best dose of gefitinib ...
Status
Terminated
Location
University of Colorado
Start Date
2002-02
Trial ID
NCT00033449
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Phase II trial to study the effectiveness of combining gefitinib with fluor...
Status
Terminated
Location
Abramson Cancer Center of The University of Pennsylvania
Start Date
2002-10
Trial ID
NCT00052585
Treatments Being Tested
Here we are going to find a method by using available multiple drugs includ...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2014-01
Trial ID
NCT02350361
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of target...
Status
Unknown
Location
Shenzhen People's Hospital
Start Date
2018-08-31
Trial ID
NCT03656393
Treatments Being Tested
RATIONALE: Some tumors need growth factors produced by the body's white blo...
Status
Unknown
Location
AstraZeneca Pharmaceuticals LP
Start Date
2000-05
Trial ID
NCT00006049
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1999-09
Trial ID
NCT00005806
Treatments Being Tested
The purpose of this study is to evaluate the feasibility, efficacy and safe...
Status
Unknown
Location
Xinhua Hospital
Start Date
2016-07
Trial ID
NCT02836847
Treatments Being Tested
There are two different treatment modes for NSCLC patients who failed to ep...
Status
Unknown
Location
Department of Respiratory Medicne, Peking Union Medical Hospital
Start Date
2012-10
Trial ID
NCT01746277
Treatments Being Tested
RATIONALE: Biological therapies such as gefitinib may interfere with the gr...
Status
Completed
Location
Stanford Cancer Center at Stanford University Medical Center
Start Date
2001-07
Trial ID
NCT00025142
Treatments Being Tested